Clinical Conductor, created by Rochester, N.Y.-based Bio-Optronics, a provider of software and services to healthcare and life sciences organizations, has launched new enhancements to the Clinical Conductor CTMS. This oncology-focused release is the first of several and adds advanced features and functionalities designed to optimize the management and execution of oncology studies at organizations of all sizes and makeups.
While clinical trial management systems (CTMS) offer oncology-based solutions, Clinical Conductor is the only CTMS to build oncology-specific functionality directly into an already-existing CTMS workflow. The resulting outcome allows organizations to successfully run complex oncology studies while also maximizing profitability and achieving high quality clinical research results.
The first advancement in the latest release of Clinical Conductor CTMS is adaptive and dynamic protocol design. These features let organizations have precise control and understanding of the varying patient protocols within the same study. Organizations also will be able to move patients between different arms of the same study more easily, create patient visit cycles and build varying procedures by study.
Billing compliance functionality within Clinical Conductor also has been enhanced, allowing organizations managing and executing oncology studies to create multiple versions of cost-allocation grids for multi-arm trials, providing more accurate billing information with less time and effort. Also, Clinical Conductor’s financial tools accommodate complex and changing protocols, allowing organizations to effectively bill for recurring visits and other complexities that result from oncology protocol design. In addition to this, organizations can set specific Medicare coverage designations at specific sites.
Clinical Conductor CTMS also contains National Cancer Institute (NCI) reporting functionality. This added functionality allows organizations to reduce the time spent tracking information necessary for NCI Data Tables by allowing staff to compile NCI-specific information directly within Clinical Conductor. This functionality creates NCI-compliant reports and allows researchers to adhere to NCI grant requirements more easily.